Last reviewed · How we verify
NCT05649007
Post-marketing Surveillance Study of the Saphir Stem in Primary Hip Surgery
trial testing hip arthroplasty with prosthesis in Arthropathy of Hip in 630 participants. Currently enrolling.
30 September 2035
Quick facts
| Lead sponsor | Gruppo Bioimpianti S.r.l. |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 630 |
| Start date | 30 September 2022 |
| Primary completion | 30 September 2035 |
| Estimated completion | 30 September 2036 |
| Sites | 1 location across France |
Drugs / interventions tested
- hip arthroplasty with prosthesis
Conditions studied
- Arthropathy of Hip — all drugs for Arthropathy of Hip →
Sponsor
Gruppo Bioimpianti S.r.l.
Who can join
18 and older, any sex, with Arthropathy of Hip. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Post-market clinical follow up investigation on the use of saphir stem and FIN Cup or Dualis system in the treatment of pathologies requiring hip arthroplasty. The main object of the clinical investigation is the evaluation of long term survival rate of Saphir stem.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05649007
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Arthropathy of Hip
Currently open trials in the same condition.
- NCT07327372 — PENG Block With Dexmedetomidine in Older Adults · NA · recruiting
- NCT06832995 — Incidence and Risk Factors for Post-Anesthetic Morphine Titration in Recovery Room After Hip and Knee Arthroplasties · active not recruiting
- NCT05647629 — Observational Study of the Development of Low Back Pain After Total Hip Arthroplasty. · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05649007 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gruppo Bioimpianti S.r.l.
- Last refreshed: 13 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05649007.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing